ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681632 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681632; 2) Community: the network communities that were significantly associated with the response to NSC 681632; 3) Molecule: the relationships between components within communities and NSC 681632; 4) MDR: the compounds that were significantly associated with the NSC 681632.

NSC Compound Enrichment Correlation
NSC 236580 .beta.-Alanine, N-[N-[N-[N-[1-(D-2-hydroxy-4-methyl-1-oxopentyl)-L-prolyl]-L-isoleucyl]-N-methyl-L-valyl]-N-methyl-L-alanyl]-, .rho.-lactone 0.0352383000003058 0.33109448
NSC 268993 Deferoxamine hydrochloride 0.0352383000003058 0.47092919
NSC 301477 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 0.0352383000003058 0.69588124
NSC 364830 Camptothecin Derivative 0.0352383000003058 0.8223355
NSC 409304 Null 0.0352383000003058 0.034800024
NSC 628562 4H-1,3,2-Benzodioxastannin-4-one, 7-amino-2,2-diphenyl- 0.0352383000003058 0.19639854
NSC 640084 Null 0.0352383000003058 0.11497245
NSC 641225 Null 0.0352383000003058 0.40683805
NSC 648114 ANTINEOPLASTIC-D648114 0.0352383000003058 0.59732014
NSC 662253 Null 0.0352383000003058 0.12475274
Total:69  Current:50    [First] [Prev] [Next] [Last]